![](/img/cover-not-exists.png)
Genomic profiling of patients with metastatic castration-resistant prostate cancer (mCRPC) for the evaluation of rucaparib: Next-generation sequencing (NGS) of tumour tissue and cell-free DNA (cfDNA)
Piulats, J.M., Abida, W., McDermott, R., Shapiro, J.D., Ostler, P., Reaume, M.N., Mejlholm, I., Byard, I., Hussain, A., Morris, D., Campbell, D., Burke, J., Laguerre, B., Reid, A., Voog, E., BenjellouVolume:
18
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)30351-3
Date:
March, 2019
File:
PDF, 91 KB
2019